SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹3.41 Cr | ₹3.27 Cr | ₹3.29 Cr | ₹3.26 Cr | ₹3.20 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹3.41 Cr |
| Mar2024 | ₹3.27 Cr |
| Mar2023 | ₹3.29 Cr |
| Mar2022 | ₹3.26 Cr |
| Mar2021 | ₹3.20 Cr |
How is Deferred Tax Assets / Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.41 Cr | 4.22 | |
| Mar2024 | ₹3.27 Cr | -0.43 | |
| Mar2023 | ₹3.29 Cr | 0.83 | |
| Mar2022 | ₹3.26 Cr | 1.78 | |
| Mar2021 | ₹3.20 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,401.0 Cr | 9.4% | -9.7% | 142% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 9.4% |
-9.7% |
142% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses